Search Results

LLS Announced a Collaboration with the National Cancer Institute and Children’s Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia

The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG)…

LLS ANNOUNCES COLLABORATION WITH THE NATIONAL CANCER INSTITUTE AND CHILDREN’S ONCOLOGY GROUP ON A GLOBAL MASTER CLINICAL TRIAL FOR CHILDREN WITH ACUTE LEUKEMIA

June , (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Child…

News Release

Development of a clinical program for myeloid cancer prevention

The majority of myeloid cancers remain incurable. We previously showed that individuals at risk can be identified years in advance, indicating that pr…

A young mixed race woman with cancer laughs while spending time outdoors with her supportive and loving parents. Their arms are linked and they are walking in a forested area. All of the individuals are smiling and feeling positive about the future.

Finding strength together: Emotional support for families facing cancer

Table of contents:Finding strength together: Emotional support for families facing cancerUnderstanding the emotional impact of cancer on familiesHow …

Blog

Communicating with your blood cancer specialist or care team

How to advocate for your careLearn about your diagnosis and treatment optionsConsider clinical trialsDon’t be afraid to seek a second opinionUnderstan…

Support Resources

Blood Cancer United, formerly The Leukemia & Lymphoma Society, Announces New Funding for Lifesaving Cancer Breakthroughs

With the latest funding round, Blood Cancer United’s cumulative research funding tops $ billion, continuing to help increase survival rates and improv…

Research: Grants

RECONNECT: Overcoming Racial and Ethnic Inequity in Clinical Trial Enrollment via Clinical Trial Nurse Navigation and Provider Communication Training

This study will implement a didactic course for providers to improve the quality of communication around structural racism, mistrust, implicit biases…

BRAF and BCL2 coinhibition with vemurafenib and venetoclax as a rational, short, all-oral targeted therapy for relapsed/refractory hairy cell leukemia

We will test the first fully oral, drug combination that simultaneously blocks two different key survival mechanisms in hairy cell leukemia. First, i…

Establishing longitudinal outcomes and clinical prognosticators in pediatric and young adult B-ALL after commercially available CD19-CAR T cells

While many immunotherapy studies in children with leukemia focus on establishing early responses, this project studies what life is like, and what hea…

Image of book "After Cancer Guide for Your New Life"

β-Hydroxybutyrate To Enhance CAR T Cell Immunotherapy Against Hematological Cancers

This project aims to enhance CAR therapy, a promising treatment for blood cancers, by leveraging the ketogenic diet and its key byproduct, (BHB). We…

Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night

Rye Brook, NY, March , – The Leukemia & Lymphoma Society (LLS) announced today that BeiGene, Ltd., a global oncology company, has signed a partnersh…

The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care

LLS’s Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care an…

News Release

Harnessing the epigenome to advance the classification and understanding of molecular mechanisms underlying hairy cell leukemia variant patients

Patients with B cell malignancies who do not fall into a distinct pathological disease category pose a challenge for patient care, and patient classif…